Synchron Brain Computer InterfaceLearn More
Synchron is a Brain Computer Interface company based in Campbell, California and Melbourne, Australia. We are developing minimally-invasive technology for safe and rapid implantation of miniaturized electronic medical devices with broadband capability.
Our products are designed to help diagnose and treat a range of neurological disorders including speech deficit, paralysis, epilepsy, movement disorders and depression.
Explore the science behind our technology.
Broadband signals. Minimally invasive. Stentrode™Find out more
The Story of Synchron
The company was founded in 2012 after a cold-call pitch to the Pentagon with a new concept for a Brain Computer Interface by Thomas Oxley. Seed funding was provided by DARPA, ONR Global and the National Health and Medical Research Council of Australia. The company (formerly known as SmartStent) spun out of the University of Melbourne, and continues to have close ties to the Vascular Bionics Laboratory in the Department of Medicine (Royal Melbourne Hospital). Series A funding was led by NeuroTechnology Investors, with veteran neurovascular entrepreneur Martin Dieck joining the board of directors as Chairman. The company has its corporate headquarters in Silicon Valley, in Campbell, California.